Study Evaluating Safety And Efficacy Of Moroctocog Alfa (AF-CC) In Previously Treated Hemophilia A Patients

NCT00914459 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia A

Interventions

BIOLOGICAL: Moroctocog alfa ( AF-CC)
PROCEDURE: Laboratory tests

Sponsor

Pfizer